Genetic characteristics of myoadenylate deaminase deficiency.

Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise. J Nutr Metab (2010) 0.96

Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J Physiol (2001) 0.95

Association of Mitochondrial Dysfunction and Fatigue: A Review of the Literature. BBA Clin (2014) 0.93

Primary, secondary, and coincidental types of myoadenylate deaminase deficiency. Ann Neurol (1999) 0.84

The effect of AMPD1 genotype on blood flow response to sprint exercise. Eur J Appl Physiol (2008) 0.83

AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance. J Neurol (2008) 0.82

Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study. PLoS One (2015) 0.75

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet (1995) 5.58

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet (1998) 4.96

FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet (1993) 4.21

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet (1997) 3.56

The frequency of lysosomal storage diseases in The Netherlands. Hum Genet (1999) 3.54

Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53

Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene (1999) 3.00

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys (1994) 2.97

Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet (1996) 2.68

Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet (1998) 2.62

Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr (1998) 2.26

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol (1993) 2.25

Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int (2001) 2.19

Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet (1990) 2.09

Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med (1994) 2.03

Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology (2010) 2.01

Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93

Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet (1999) 1.92

Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem (1989) 1.91

Complex regional pain syndrome type I (RSD): pathology of skeletal muscle and peripheral nerve. Neurology (1998) 1.86

Performance of near-infrared spectroscopy in measuring local O(2) consumption and blood flow in skeletal muscle. J Appl Physiol (1985) (2001) 1.86

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology (2010) 1.80

Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur J Hum Genet (2007) 1.76

Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain (2000) 1.75

Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology (2004) 1.73

Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol (1999) 1.72

Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat (2000) 1.72

Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet (1996) 1.71

A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol (1993) 1.70

Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int (2007) 1.70

Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet (1994) 1.69

Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66

Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology (2000) 1.63

Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int (2006) 1.60

Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta (1992) 1.59

Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity. Hum Mol Genet (2000) 1.56

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis (2006) 1.54

Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood (1996) 1.51

Idiopathic neuralgic amyotrophy in children. A distinct phenotype compared to the adult form. Neuropediatrics (2000) 1.50

FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet (2004) 1.50

The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet (1999) 1.48

Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47

A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr (1986) 1.46

Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem Biophys Res Commun (2000) 1.46

Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr (2000) 1.45

Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology (2008) 1.45

Adipose tissue thickness affects in vivo quantitative near-IR spectroscopy in human skeletal muscle. Clin Sci (Lond) (2001) 1.45

Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry (2005) 1.45

Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol (1992) 1.44

Syncope or seizure? A matter of opinion. Clin Neurol Neurosurg (1992) 1.43

Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol (2001) 1.42

Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem (2003) 1.42

Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest (1996) 1.42

Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet (1996) 1.42

Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology (2007) 1.41

Familial adult-onset muscular dystrophy with leukoencephalopathy. Ann Neurol (1992) 1.40

Should all patients with malignant astrocytoma have postoperative radiotherapy? Acta Neurochir (Wien) (1991) 1.39

The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve Suppl (1995) 1.39

[The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time]. Ned Tijdschr Geneeskd (2003) 1.38

[Clinical reasoning and decision making in practice. A 23 year old woman with malaise, anorexia, fever and behavior changes]. Ned Tijdschr Geneeskd (2004) 1.38

Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol (1991) 1.38

De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet (2000) 1.37

Transient loss of consciousness: the value of the history for distinguishing seizure from syncope. J Neurol (1991) 1.36

Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet (2000) 1.35

Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics (1991) 1.35

Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35

Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35

Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet (1998) 1.34

Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem (1992) 1.34

A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci U S A (1999) 1.33

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med (2012) 1.30

Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis (1995) 1.28

Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol (1998) 1.25

Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids. Neuroradiology (2005) 1.25

Congenital disorder of glycosylation type Ix: review of clinical spectrum and diagnostic steps. J Inherit Metab Dis (2008) 1.23

Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening. J Neurol (2007) 1.23

Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging (1990) 1.22

Ophthalmological abnormalities in children with congenital disorders of glycosylation type I. Br J Ophthalmol (2008) 1.21

Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry (2004) 1.21

Localization of a gene for Möbius syndrome to chromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet (1996) 1.21

D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology (2003) 1.20

Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20

Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant. Neurology (2008) 1.20

A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19

Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review. Eur J Pediatr (2009) 1.19

Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions. Genomics (1994) 1.19

Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol (1995) 1.18

Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles. Neurology (2003) 1.18

Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol Genet Metab (2007) 1.18

Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain (1999) 1.17